downloadDownload

The Kappa Partial Agonist PPL-103 as a Potential Cocaine Abuse Pharmacotherapy

assignment_turned_inproject01 Aug 2018(Started)-31 Jan 2021(Ended)Closed

Funder: National Institutes of HealthProject code: 1R41DA044894-01A1

Funded under: NATIONAL INSTITUTE ON DRUG ABUSE Funder Contribution: 186,687 USD

The Kappa Partial Agonist PPL-103 as a Potential Cocaine Abuse Pharmacotherapy

- Summary
- DMPs

Partners

Acceleron Pharma (United States)

Data Management Plans

Start a new DMP in Argos

Select content type to embed

All Research products

arrow_drop_down

<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=nih_________::9a801468b5de74182e2010acdd6a4d06&type=result"></script>');
-->
</script>

COPY SCRIPT

For further information contact us at helpdesk@openaire.eu

The Kappa Partial Agonist PPL-103 as a Potential Cocaine Abuse Pharmacotherapy

The Kappa Partial Agonist PPL-103 as a Potential Cocaine Abuse Pharmacotherapy

Loading